Background: S100B (S100␤) is a member of the S100 family of small calciumbinding proteins: members of this family contain two helix-loop-helix calciumbinding motifs and interact with a wide range of proteins involved mainly in the cytoskeleton and cell proliferation. S100B is a neurite-extension factor and levels of S100B are elevated in the brains of patients with Alzheimer's disease or Down's syndrome: the pattern of S100B overexpression in Alzheimer's disease correlates with the pattern of neuritic-plaque formation. Identification of a growing class of S100 proteins and the likely neurochemical importance of S100B make the determination of the structure of S100B of interest.
Introduction S100B (S100␤) is a member of a group of low molecular weight (7-11 kDa) acidic calcium-binding proteins that contain two helix-loop-helix calcium-binding motifs [1] [2] [3] . The N-terminal calcium-binding loop is unusual in that it is composed of 14 amino acids and uses mainly backbone carbonyl oxygens as calcium ligands. In contrast, the classical EF-hand contains only 12 amino acids and uses mainly ligands from the amino acid side chains to coordinate calcium [4] . S100 proteins also contain hydrophobic regions at the N and C termini. These regions are conserved among the members of the group even when their amino acid sequences are not. The discovery of a gene cluster of nine S100 proteins led to a new nomenclature [5] for these proteins (e.g. S100B for S100␤) and this is used in the text.
A number of biochemical activities have been reported for S100B, including effects on cytoskeletal systems, protein phosphorylation and enzyme activities [6, 7] . In addition to these intracellular functions, a disulphide-linked dimer of S100B has neurotrophic activity on selected neuronal populations and mitogenic and morphogenic activity on astrocytes [6, 7] . The levels of S100B in the brain are elevated in Alzheimer's disease and Down's syndrome, with S100B localized primarily in activated astrocytes surrounding neuritic plaques [8] . The pattern of S100B overexpression in Alzheimer's disease correlates with the pattern of neuriticplaque formation [9] , suggesting a possible relationship between S100B levels and the regional distribution of Alzheimer neuropathology.
Among the members of the S100 family of proteins, structural information only exists for calbindin D 9k (CALB3, subsequently referred to as calbindin) and S100A6 (calcyclin) [10] . In the case of calbindin, X-ray [11] and NMR [12] [13] [14] structures are available. Calbindin is the protein least similar to the remainder of the S100 group, sharing only 27 % identity with S100B. It is also somewhat smaller than the other proteins, lacks the C-terminal hydrophobic region, and is a monomer in solution whereas the other S100 proteins are dimers. It is therefore not clear that calbindin provides a satisfactory model for the structures of the other S100 proteins. The identification of a growing class of S100 proteins and the likely neurochemical importance of S100B make the determination of the structure of S100B of interest. Two preliminary crystallization notes have appeared [15, 16] but as yet no structure has been reported. Since we reported the backbone resonance assignments and secondary structure of bovine S100B [17] , these have been confirmed for rat S100B. [18] An NMR structure, determined from two-dimensional (2D) homonuclear NMR data, of S100A6 (calcyclin), another dimeric member of the Table 1 Chemical shift* values for S100B at pH 6.5 and 314 K.
Residue
Exchange † 1 5 N( 1 H) 13 C␣( 1 H␣) 13 C␤( 1 H␤) other 13 S100 family of proteins, has recently been published and revealed a novel dimeric fold [10] .
We now report the full 3D structure of the reduced, calcium-free S100B dimer, calculated from 3D NMR data. The structure consists of two four-helix-bundle monomers which interact with each other in an antiparallel manner. The fourth helix of each monomer runs close to the equivalent helix on the other monomer for almost the whole of its length. We find that the N-terminal calcium-binding loop is preformed, ready to bind calcium, but that the Cterminal loop would need to change conformation before calcium could bind.
Results
Resonance assignment and structure calculation
The structure of bovine calcium-free S100B protein in solution was determined using constraints derived from 3D NMR data. The structure determination of a homodimer such as S100B is hampered by the fact that it is impossible to distinguish unequivocally between the inter-and intramonomer NOEs without resorting to asymmetric labelling. The problem is exacerbated by the ambiguity of many assignments of NOESY crosspeaks in 3D NOESY-HMQC experiments in which several nuclei have similar chemical shifts. These difficulties have caused us to use a method for structure calculation that incorporates a treatment of ambiguity into the NOESY crosspeak assignments [19] and in whether NOEs are intra-or intermonomer [20] .
Three 3D NOESY-HMQC datasets were used to derive the constraints used in the calculation of the structure. The constraints were derived by determination of the NOE volumes, as described in the Materials and methods section. A family of S100B monomer structures was calculated using only the uniquely assigned intramonomer constraints. The monomers with the lowest energy were duplicated and docked to form dimers using simulated annealing, gradually increasing the weight of the uniquely assigned intermonomer NOE constraints. The identities of the ambiguous NOE restraints were then determined by iteration through the structure determination protocol.
The backbones of the 25 lowest-energy structures are shown in Figure 1a and statistics on these structures are given in Table 2 . Inclusion of a further 12 structures that were next lowest in energy only increased the backbone rms deviation from 0.71 to 0.74 Å. The rms deviation of the individual ␣-carbon atoms to the average structure is shown in Figure 1b , which demonstrates that the structures are best defined for the helical structure elements and least well defined for the residues at the C terminus. A stereo view of an ␣-carbon trace is shown in Figure 2 . These structures are based on a larger number of NOEs than the recently reported structure of S100A6 (calcyclin), and hence are better defined. Analysis of the Ramachandran plot shows that only 0.4 % of the residues fall into the disallowed region of the plot and no individual residue consistently falls into this region for every one of the 25 structures. Analysis of the average structure shows that Asp23 in the N-terminal calcium-binding loop and Glu86, close to the C terminus and which was not assigned, are in locations furthest from the favoured regions on this plot.
Structure description
As shown in Figure 3 , each subunit of the S100B dimer consists of an up-down-up-down four-helix bundle. The pairs of helices, I + II and III + IV, are linked by two helix-loop-helix calcium-binding loops, with a short antiparallel ␤ sheet between residues at the end of each loop. Helices II and III are linked by a loop region that contains a single turn of helix. The secondary structure is essentially as reported previously [17] , although the second helix is now seen to run beyond Asn37-Glu39 in 24 structures and to Asn38 in the remaining structure. The long fourth helix starts at Phe70 in all the structures and terminates at Ala83, as before, in 20 structures. In the remaining five structures this helix runs to Thr81, Thr82 or Cys84.
The structures are able to account for many of the slowexchanging amides observed in residues whose amides would not be predicted to be involved in secondary structures. In common with Ser24 of calbindin [14] , the backbone oxygen of Lys28, the C-terminal residue of the first ␤ strand, provides the first hydrogen bond to the second helix (to Leu32 HN) in all structures (see Fig. 4 for an alignment of the amino-acid sequences and secondary structures of S100B, calbindin and calcyclin). The Lys29 backbone oxygen forms a hydrogen bond to the HN of Ensemble of S100B backbone structures. (a) The family of S100B structures were overlaid on their C␣ positions using Insight II (Biosym). Each monomer is shown in a different colour. Helices I, II,and IV are labeled on the red monomer and helix III′ on the other (blue) monomer (b) The root mean square deviation of the ␣ carbons from the average structure in the ensemble of structures is shown against the aminoacid numbering and the secondary-structure elements.
Lys33 in 23 structures although this was not constrained in the input data. Consistent with the longer length of the second helix, a hydrogen bond was found from Glu34 backbone oxygen to Asn38 HN. The slow exchange of the HN of Leu40 is probably caused by a hydrogen bond to Ile36 observed in 14 structures, although the ␣H chemical shift is not consistent with standard helical geometry at this point. The carbonyl of Leu40 forms hydrogen bonds with Phe43 (four structures) and Leu44 (17 structures) and could account for the slow exchange observed at these sites. At the N terminus of the helix running from Glu50-Ser62, Val53 is hydrogen bonded to Glu49 in 21 structures. For the helix from Phe70 to Ala83, the carbonyl of Asp69, the last residue of the ␤ strand, provides the first hydrogen bond of the helix (to Phe73) in all structures. The Phe70 to Met74 NH hydrogen bond present in 14 structures accounts for the slow exchange observed at Met74. In contrast to the observations on calbindin [14] , we found no evidence for N capping of the N-terminal helix by Ser1 O␥, and in the other helices where serine or threonine is present to provide N capping in calbindin the equivalent residues in S100B are not capable of N capping (Lys28 and Val52, see alignment in Fig. 4 ). In the C-terminal helix, Asp69 takes the place of Ser62 in calbindin but its side chain is not correctly oriented to hydrogen bond to Glu72, and the latter does not show slow HN exchange.
The dimer is formed by the packing of the two C-terminal helices against each other in an antiparallel fashion, shown in Figure 3 . These helices are packed at an angle of 154 ± 8°, close to the value of 143 ± 7° for calcyclin. Most of the NOEs defining the dimer interface are between side chains of residues in these helices. In addition, further dimer NOEs were located between the N-terminal helices and the residues of helix IV of the other monomer. We have also been able to identify NOEs between residues of the N-terminal helices and residues in the 39-40 region, which comes close to the N terminus of the other monomer. These are from Val7 to Leu40, Lys5 to Glu39 and Leu40, Val77 to Leu10 and Val7, and from Thr81 to Ile11. It is notable that many of the residues forming the dimer interface are absent in calbindin, which has only 75 residues and is a monomer in solution.
The hydrophobic core of the protein, shown in Figure 5a , is made up of Leu10, Val13, Phe14, Leu32, Ile36, Phe43, Val52, Val56, Leu60, Phe76 and Ile80, all of which are conserved or conservatively substituted when compared with calbindin. The 1 rotamer distributions of these residues have been compared with calbindin [14] . The most significant difference is in Val13, which is trans in S100B whereas the equivalent residue in calbindin, Ile9, is gauche plus. The only other differences are that Leu32 and Val56 in S100B are always trans whereas their equivalents in calbindin show mixed conformations. The monomer hydrophobic core is extended by Val7, Phe70, Met74, Ala75, Ala78, Thr82 and Phe88 so that the dimer has one continuous core of hydrophobic residues. Of these additional residues, only Phe70 is conserved in calbindin and shows a different packing in that the 1 rotamer distribution is gauche plus rather than trans, as found for Phe63 in calbindin. In S100B,
Research Article Solution structure of S100B protein Kilby et al. 1045 Table 2 Summary of data on the ensemble of 25 S100B structures. 
Figure 2
Stereo view of the backbone of S100B. A single member of the family of structures is shown, with every tenth amino acid numbered.
this brings the ring of Phe70 away from the monomer to which it is chemically bonded and into close proximity with residues of the other monomer. If this orientation existed in calbindin it would leave Phe63 very exposed. The unexpected absence of Ile47 from the hydrophobic core of the protein is illustrated in Figure 5b .
The interhelix angles of S100B are shown in Table 3 where they are compared with those of calcyclin and calbindin. Only the angle between helices II and IV differs by greater than two standard deviations from the value for calcyclin and this deviation is towards the value seen in calbindin. However, by observation of the actual structures the biggest difference among these three structures is in the location of helix III, which is much closer to being antiparallel to helix IV in S100B than in the other two proteins. The NOE contacts in this region between helix III and the surrounding two helices are mainly hydrophobic in nature being mediated by NOEs from Val52, Val56, Thr59 and Leu60 on helix III to hydrophobic residues Leu32, Phe76, Ala83 and Met79. Some NOE contacts were also observed involving charged residues, specifically from Leu60 to Lys29 and Lys33 side chains and from Val56 to Glu46 but there were no obvious ion pairs.
With the larger number of NOEs used in this calculation compared with that of the structure of calcyclin, we are able to define the calcium-binding loops more clearly. The Nterminal loop is made up of residues Ser18 to Glu31. This loop is in a conformation which would be ready to bind calcium. Important contacts which determine the structure of this loop have been identified; for example, NOEs from Ser18 C␣H to Leu27 C␣H and from Tyr17 to Leu35, the latter defining the hydrophobic contacts across the ends of
Figure 4
Alignment of S100B, calbindin and calcyclin sequences and reported secondary structures. the calcium-binding loop. The calcium ligands of this loop are mainly backbone carbonyls and those from Ser18, Asp23 and Lys26 are all pointed towards the centre of the loop. In addition, the bidentate ligand from the side-chain carboxylate of Glu31 points back into the calcium loop, as illustrated in Figure 5 . Only the carbonyl of Glu21 is not oriented correctly for calcium ligation.
In contrast, the C-terminal calcium-binding loop takes up a different form. The third long helix is oriented differently to that of calcium-free calbindin. It is almost antiparallel to the fourth helix, with its residues further away from the ␤ strand at the end of the calcium-binding loop. NOEs which would be expected by reference to the structure of calcium-free calbindin [14] to define the C-terminal EFhand type calcium-binding loop were found to be absent. In particular, NOEs from Cys68 C␣H and C␤H 2 to Leu60 C␦H 3 and C␤H were absent as were the NOEs from Asp61 C␣H and C␤H 2 to Cys68 C␣H. All these NOEs are between well resolved resonances and would be visible even in 2D spectra. Closer examination of the loop shows that three of the calcium-binding ligands, the side chain of Asp63, the carbonyl of Glu67 and the side chain of Glu72, are well placed for calcium binding. However, the remaining ligands, the side chains of Asp61 and Asp65, point away from the loop and would need to change conformation to bind calcium (Fig. 5d ).
Discussion
The determination of the structure of the S100B dimer confirms that the novel overall dimer structure found recently for calcyclin [10] is the common fold for the dimeric S100 proteins. We found that the same residues along the C-terminal helix and several residues on the Nterminal helix make up the majority of the contacts that define the interface. Residues that are most important in
Research Article Solution structure of S100B protein Kilby et al. 1047 Table 3 Comparision of the helix angles in S100B with calbindin and calcyclin (S100A6).
Helices S100B Calcyclin Calbindin I-II 129.5° ± 3.4°126° ± 27°123° ± 3°I -III -66.5° ± 2.4°-83° ± 22°-109° ± 9°I -IV 118.6° ± 2.2°119° ± 17°128° ± 4°I I-III 143.6° ± 2.9°144° ± 15°124° ± 7°I I-IV -46.4° ± 3.2°-16° ± 10°-34° ± 4°I II-IV 164.3° ± 4.0°145° ± 16°118° ± 8°I V-IV′ 154.6° ± 8.6°143° ± 7°-defining this surface are Thr82, Phe70, Thr81, Phe88, Phe87 from near to the C terminus and residues Ile11 and Phe14 from the N-terminal helix. A few residues from the N terminus also show NOEs to residues Glu39 and Leu40. It is notable that these two residues are conserved in almost all S100 group proteins. These NOEs define the location of the N-terminal helix in a way that was not identified for calcyclin, and as a result the structure reported here for S100B is more compact than that reported for calcyclin, with the N-terminal helices closer to the main core of the dimer.
The surface of S100B is characterized by many charged residues. The spread of charged residues, predominantly negatively charged, is quite even over the face of the dimer that is shown in Figure 6a . On the opposite side (Fig. 6b) there is a much stronger concentration of negative charges, especially in a cleft in the centre of the molecule: as noted in calcyclin [10] , this is a potential binding cleft. In spacefilling models no hydrophobic residues are even partly visible on this side. However, despite the high level of surface charges on S100B and its high solubility in water, there are several hydrophobic residues exposed on the surface. Most notably, Ile47 is very exposed in the loop region between helices II and III (Fig. 5b) . Observation of the NOEs to Ile47 C␦H 3 and C␥H 3 show none from the aromatic protons of Phe43, or from the methyl groups of Val52 and Val53, which are the residues of the hydrophobic core in this region of the protein. Another residue which is partly exposed is Val8. It is notable that hydrophobic residues are not normally present at these locations in other S100 proteins. Leu44 and Val53 are also partly exposed.
Several regions of the molecules of the S100 family have been proposed to interact with their effector molecules, and knowledge of the structure of S100B allows us to comment on the likelihood of the interaction at each of these locations. S100B forms disulphide bridges to tau protein through either Cys68 or Cys84 [21] . Amino acids four to seven at the N terminus of calcyclin, are suggested to bind to annexin XI. [22] A peptide from S100A8 (CP-10) corresponding to the region between the second and third predicted helices mimicked most of the cytokine effect of the whole protein upon phagocytic cells [23] . These proposed binding sites near the N terminus and on the loop between helices II and III are consistent with the structure, as both of these regions are exposed and are also the least well conserved regions of the protein. In addition, they also both contain exposed hydrophobic residues, as noted above. In the case of S100A10 (p11), the binding site of annexin II on S100A10 has been suggested to involve the residues 85-91 and in particular the residues Tyr85 and Phe86 [24] . However, these residues (equivalent to Phe87 and Phe88 in S100B) are buried in the dimer interface in S100B and are crucial to the hydrophobic core of the dimer. The loss of binding upon mutation of these residues may therefore be due to the disruption of the dimer structure rather than to specific loss of the binding site for annexin II. We have recently observed significant chemical-shift changes in the spectrum of 15 N-labelled S100B when it binds to neurocalcin ␦, a member of the recoverin family of calcium-binding proteins [25] , and are currently using these changes to determine the binding site of neurocalcin ␦ on the S100B dimer.
This structure also has implications for the activity of S100B as a neurite-extension factor. S100B is only active in this assay when calcium is bound and when S100B is in a disulphide-bridged form. It has not yet been established whether this disulphide bridge is intradimer or interdimer. The structure of S100B shows that Cys68 is about 21 Å away from Cys84 on the other monomer and a substantial structural rearrangement of the C terminus would be required to form disulphide bridges within the dimer structure. Disulphide-bridge formation between two dimers in the absence of calcium would be unlikely to involve Cys68 as the side chain of this residue points into the core of the molecule, but Cys84 is more exposed and could therefore form a disulphide bridge in this way (Fig. 5b) . We can also comment on the effect of calcium on the S100B dimer. Clearly the apoprotein structure shows that the C-terminal calcium-binding loop is not correctly formed for calcium binding. Several of the calcium-liganding side chains do not point to the calcium-binding site and the angle between helices III and IV is larger than we would expect even in a closed form of a calcium-binding protein.
If the C-terminal calcium-binding loop, as we would expect, formed a classical EF-hand structure on binding calcium, then helix III would move significantly with respect to helices II and IV. Such a change in conformation might be the signal by which S100B proteins are activated to bind to their effector molecules. It might also be that the conformational changes in S100 proteins that are calcium regulated are different from the calcium buffer calbindin and more similar to the regulatory domains of calmodulin or troponin C. In these latter proteins, when calcium is bound the whole domain changes shape to an open form with exposed hydrophobic surfaces. If such a change takes place in S100B, it might bring together one cysteine from each monomer to form an intermonomer disulphide bridge. The answers to these questions await our structural studies on calcium-bound S100B, which are currently in progress.
Biological implications
S100B (S100␤) is a member of the S100 family of low molecular weight (10-12 kDa) calcium-binding proteins. S100B is a neurite-extension factor and interacts with several cytoskeletal proteins and protein kinases. The other S100 proteins interact, in a calcium-dependent manner, with a wide range of proteins involved mainly in the cytoskeleton and in cell proliferation.
In order to understand the calcium activation and interactions of S100 proteins, knowledge about their three-dimensional structures is essential. Of the S100 proteins, structures have only been reported for the monomeric calbindin D 9k , which lacks N-and C-terminal hydrophobic regions, and recently S100A6 (calcyclin) at relatively low resolution. We have now determined the structure of the S100B dimer in the calcium-free state.
The main structural difference between S100B and calbindin D 9k is in the location of the third helix. In S100B this helix is almost antiparallel to the fourth helix whereas in calbindin the third helix is tilted 40° further away from antiparallel. As a consequence of this, the C-terminal calcium-binding loop in S100B, which is between these helices, is not in a conformation ready to bind calcium. We expect that calcium binding will cause changes in the conformation of this loop. The dimer is formed by antiparallel packing of the two C-terminal helices against each other so that the hydrophobic core extends through the dimer interface.
The structure shows the regions through which S100 proteins are predicted to interact with their target proteins. For example, S100B binds to tau protein through a cysteine, and of the two cysteines, only Cys84 is exposed. In contrast, residues equivalent to Phe87 and Phe88, which are buried in the dimer interface of S100B, have been reported to be crucial for binding of S100A10 (p11) to annexin II. These residues are probably important for dimer formation. However, detailed knowledge of S100-effector binding awaits the determination of the structures of calcium-bound S100B and its effector complexes.
Materials and methods

Sample preparation
Two samples of [ 13 C, 15 N]-labelled S100B were prepared. Each was expressed and purified from E. coli as described previously [17] with the following modifications. Labelling was carried out in 2 litres of 2 × M9 media which contained 1 g l -1 of uniformly labelled 13 
NMR spectroscopy
3D HNCA [26] and HCCH-TOCSY [27] experiments were acquired on a Bruker AMX600 spectrometer. 3D CBCA(CO)NH [26] and 13 Cedited NOESY-HMQC [28] experiments (100 ms mixing time), optimized for detection of NOEs to aliphatic or aromatic protons, were acquired on a Bruker DMX 500 spectrometer. 2D double quantum filtered correlation spectroscopy (COSY) [29] and NOESY [30] were acquired a Bruker AM500 spectrometer. The HNCA experiment was acquired in 512 × 34 × 52 ( 1 H, 15 N, 13 C) complex points using States quadrature detection in the 15 N and 13 C dimensions and transformed to a matrix of 256 × 256 × 128 points. The HCCH-TOCSY was acquired in 2048 × 70 × 200 ( 1 H, 13 C, 1 H) real points using time proportional phase incrementation (TPPI) for quadrature detection of indirectly acquired dimensions and processed with zero filling to 512 × 128 × 256 real points. The 3D 13 C-filtered NOESY-HMQC experiments were acquired in 2048 × 70 × 200 ( 1 H, 13 C, 1 H) real points and all processed in a similar manner with zero filling to matrices of 256 × 128 × 512 points. In the NOESY-HMQC experiment to detect NOEs to aliphatic protons the 13 C dimension was folded once and the experiment processed twice with different phasing parameters in the 13 C dimension to permit analysis of the differently phased sets of peaks. Window functions were Gaussian (Gaussian broadening of 0.12 Hz and linebroadening of -12 Hz) in the acquisition dimension and sine-squared (70° shift) in the other dimensions.
Peak picking and volume integration
Peaks were picked automatically in Felix 2.3.0 software (Biosym). Volumes of peaks in the 3D spectra were measured using in house software interfaced to Felix [31] .
Resonance assignments
Assignments of the 13 C C␣ and C␤ shifts of the protein were made from the CBCA(CO)NH and HNCA experiments. Other 13 C shifts and assignments of the aromatic proton chemical shifts were made from the 13 Cedited NOESY-HMQC experiments. Assignments were transferred from the assignment table, using an awk script, to the picked peaks of the NOESY experiments using different tolerances: ± 0.02 ppm for the 1 H acquisition dimension, ± 0.4 ppm for 13 C or 15 N and ± 0.04 for the indirectly acquired 1 H dimension. NOE destination nuclei were assigned if both the 1 H and heteronuclear chemical shifts matched the table of assignments. NOE origin chemical shifts were assigned to any nucleus that had a chemical shift within the specified range. NOEs were considered unique if the origin and destination nuclei were each assigned to only one set of magnetically equivalent nuclei. If two or more possibilities existed NOEs were treated as ambiguous. The database was then edited so that any intraresidue, sequential or secondary-structure defining NOEs were assigned uniquely.
Calibration of distances
Distances were calibrated using a line of best fit through a plot of volume against 1/r 6 for sets of fixed distances or distances that can be defined by the secondary structure. Upper limits were set at the greater of either two standard deviations or 20 % greater than the target distance. The standard deviations are the deviations of the NOE-derived distances to their corresponding fixed distances. Lower limits were set at 40 % less than the target distance. Uniquely assigned NOE volumes were corrected to permit the use of centre-averaged restraints. Ambiguously assigned NOEs were not corrected and for these sum averaging was used.
Structure calculation
Structures of S100B were calculated using the distance geometry simulated annealing protocol in X-PLOR [32] . The structure of the monomer was first determined using the uniquely assigned intramolecular NOEs. The method for this is described in the dg_sub_embed.inp and dgsa.inp protocols in the X-PLOR manual. The input dataset consisted of 588 intraresidue; 199 sequential; 28 i,i+2; 65 i,i+3; 4 i,i+4; and 20 long range uniquely assigned NOE restraints. There were 35 hydrogen-bond restraints of 2.05 ± 0.25 Å for the ␣ helices that we had identified previously [17] and one for the ␤ sheet. Weak dihedral angle constraints of ϕ = -60 ± 30°, ψ = -40 ± 60° for 60 residues in helices and ϕ = -120 ± 30°, ψ = -120 ± 60° for seven residues in ␤-strands were included [10] . These constraints were included for helical residues only where the ␣H chemical-shift indices predicted helical structure and when double quantum filtered COSY HN-␣H crosspeaks were weak. For ␤-strand structure these constraints were included where ␣H chemical-shift indices predicted helical structure and when double quantum filtered COSY HN-␣H crosspeaks were strong and showed large coupling constants. On the basis of these calculations, a further 14 intraresidue; 16 sequential; 3 i,i+2; 5 i,i+3; 6 i,i+4; and 26 long-range constraints were resolved from the ambiguous data and added to the calculation. These were only resolved if no other possible assignment was within the greater of 12 Å or twice the shortest assignable distance and only if the prospective assignment was within 7 Å in the initial structures. The monomer structures were then recalculated and refined twice using simulated annealing (8000 steps, 40 ps, cooled from 2000°C, using the refine.inp protocol from the X-PLOR manual). Of the 80 initial structures, the 39 lowest energy monomer structures (all the structures of less than 1000 kcal mol -1 total energy) were used in subsequent calculations. In this process, several NOEs that were inconsistent with the structure were put aside as a set of intermonomer NOEs.
Each monomer structure was duplicated and rotated about helix IV by 180° and about an axis running through the centre of helices II and IV by 180°. The choice of axes for rotation was made to be consistent with the uniquely assigned intermonomer NOEs which were from one end to the other of helix IV, specifically between residues Phe70 and Thr82, Gln71 and Thr82, Gln71 and Ala78, and Phe70 and Phe88. The monomers were then separated by 20 Å along the latter axis. The two monomers were docked using simulated annealing by gradually increasing the scale factor of the dimer set of five NOEs, which were specifically assigned as intermonomer, from 1-50 exponentially over 2000 steps (10 ps) at 2000°C and then cooling the structure for a further 2000 steps (10 ps). These structures were then refined (12 000 steps, 60 ps) with gradual (exponential) inclusion of the ambiguous NOEs that were not defined to be either intra-or intermonomer. At this stage noncrystalline symmetry was gradually introduced from a weight of 0.1-10 kcal mol -1 Å -2 .
In these calculations, two conformations of the dimer appeared. In the first case, which almost always had the lower energy, the N-terminal helix protruded from each monomer and ran under the equivalent helix on the other monomer. This form of the dimer was formed for 19 out of 34 structures and was the most similar to the monomer structures: the N-terminal helix points away from the other helices. In the second case, which was less common (15 structures) and in all but five cases generated structures with a higher energy than any structure of the first conformation, the two monomers were docked with the first and fourth helices alongside and parallel to each other and running antiparallel to the equivalent helices on the other monomer. These structures were not favoured on energetic grounds, or on the basis of the experimental data as the most clearly observed intermonomer NOEs do not involve NOEs from one end to the other of the first helix. In addition, we did not find any long-range NOEs from the first ten amino acids on helix I to residues on helix IV of the same monomer, and the initial monomer calculations showed that helices I and IV do not run parallel to each other. On the basis of this set of 19 structures, 19 further ambiguous intermonomer restraints were uniquely assigned. These were only assigned if one pair of possible nuclei made the shortest assignable distance in all 19 structures. These NOEs were included in subsequent calculations as uniquely assigned intermonomer NOEs. 100 further monomer structures were then calculated and the 52 lowest-energy structures (all the structures with total energies of less than 1000 kcal mol -1 ) from this set docked in the same way as before. Table 4 NOEs used in the calculation of the structure of S100B*. Table 4 . An NOE was resolved (assigned as unique) only if it was assigned to the same set of atoms in all of the structures and not violated by on average more than 0.15 Å. The calculations were then repeated from the point were the ambiguous NOEs were included.
To confirm the use of the hydrogen-bond constraints in the input data, another experiment and some further calculations were performed. The amide-exchange experiment was carried out upon a sample of 1 mM 15 N-labelled S100B at 306 K and pH 6.3, using 20 mM KH 2 PO 4 buffer in addition to the normal buffer components to control the pH during lyophilisation. A further set of 90 monomer structures was generated as before without hydrogen-bond constraints. Hydrogen-bond constraints were only added to subsequent stages of the calculation for residues that showed slow or intermediate exchange and if the predicted hydrogen-bond distances violated the possible constraints by an average of less than 0.5 Å in the set of 31 lowest energy monomer structures. These monomers were refined, docked and reannealed as before with the addition of several further hydrogen bonds that subsequently satisfied the conditions above when constraints from the ambiguous NOEs were included. In this way, all of the previous hydrogen bonds were included in the set of structures except for those between residues 3-7 (0.53 Å distance violation), 8-12 (0.91 Å distance violation), 11-15 (not justified by hydrogen exchange data), 41-45 (0.56 Å distance violation) and 58-62 (no distance violation but not justified by the exchange data). As expected, the resulting structures were not significantly different from the first set.
Structures were accepted for inclusion in the final family solely on the basis of their total energies. Structures were analyzed using the PROCHECK-NMR package for secondary structure and , ψ, and χ1 angles [33] . Hydrogen bonds were located using the HBOND program in the CCP4 package [34] . This program uses an electrostatic calculation of the hydrogen-bond energy [35] . All hydrogen bonds with energies of less than -1.27 kcal mol -1 (i.e. stronger than -1.27 kcal mol -1 ) were calculated. This energy corresponds to a hydrogen bond with H to O distance of 2.50 Å and a N-H...O angle of 135°, where N and O=C are colinear.
To compare the structure of the C-terminal EF hand with calbindin, the sequence of S100B was modelled onto the structure of calbindin [14] in the calcium-free state, using the program Modeller [36] .
Accession numbers
The coordinates of the ensemble of structures have been deposited at the Brookhaven Protein Data Bank under the accession code 1cfp.
